Data Collection of Patients Admitted to the Stroke Unit
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Ghent
About this trial
The purpose of this prospective observational study is to create a database in which data will be collected from every patient admitted to the Stroke unit and who has explicitly given his or her informed consent for this data collection. The data that will be collected are part of the standard clinical data. No additional investigations, blood tests or any other tests will be performed. The purpose of this database is to conduct retrospective observational research in the future and will allow the hospital to keep track of some important quality indicators in stroke care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients admitted to the Stroke unit with a cerebrovascular disease
Patients admitted to the regular neurological ward or any other department in the University Hospital Ghent with a cerebrovascular disease who are actively followed by the department of Neurology during hospitalisation
Patients who have given their explicit informed consent for data collection
Disqualifiers
Patients who have not given informed consent for data collection
Patients who are not able to give informed consent and whose legal representative has not given informed consent
Trial population
All patients admitted to the Stroke unit (or to any other hospital ward) with a cerebrovascular disease and who have given their informed consent for data collection (or whose legal representative has given informed consent for data collection).
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Characteristics of study population
Information about patients included in the stroke database: age, gender, medical/family history
Time frame
date of inclusion until end of follow-up (12 months)2
Onset-to-door
Time between stroke onset and arrival at Emergency Department
Time frame
date of inclusiondate of inclusion until end of follow-up (12 months)3
Patients treated with acute stroke therapy
Patients treated with acute stroke therapy (i.e. thrombolysis and/or thrombectomy), start time of acute therapy
Time frame
date of inclusion until end of follow-up (12 months)4
Outcome after acute therapy
Outcome after acute therapy, assessed by NIHSS and mRS score, possible complications and imaging
Time frame
date of inclusion until end of follow-up (12 months)Secondary outcomes
1
Quality of stroke care
Quality of care at Stroke unit of the University Hospital Ghent
Time frame
date of inclusion until end of follow-up (12 months)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov